Updated April 2021
The spring update to the 2021 Patient Assistance & Reimbursement Guide has the most up-to-date information on cancer drug assistance and reimbursement programs to help your patients alleviate the financial burden of their treatment.
This guide to financial assistance contains directions on program enrollment from 45 companies, granting eligible insured, underinsured, and uninsured patients access to more than 180 oncology medications at little or no cost, including new programs for EMD Serono, G1 Therapeutics, and Oncopeptides.
The 2021 Patient Assistance & Reimbursement Guide contains:
The print version of the 2021 Patient Assistance & Reimbursement Guide was mailed to ACCC Members in January 2021.
Email your comments and feedback to Maddelynne Parker, ACCC Content Coordinator.
COVID-19 Financial Advocacy Resources
Our Financial Advocacy Boot Camp offers a dynamic online curriculum that helps you and your cancer patients navigate the complex healthcare system and pay for their treatment. Learn more about how to be an effective financial advocate.
The ACCC Oncology Drug Database contains billing and diagnosis codes, reimbursement amounts, FDA-approved indications, and contact information for every cancer drug on the market.
Access the Database